
Reset all filters
01 1ABBVIE
Reset all filters
01 110105365
Reset all filters
01 1Blank
Reset all filters
01 1Y
Reset all filters
01 12035-01-02
Patent Expiration Date : 2035-01-02
DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR
US Patent Number : 10105365
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208624
Patent Use Code : U-1889
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-02